Cardiff Oncology Inc (CRDF)
3.63
-0.11
(-2.94%)
USD |
NASDAQ |
May 17, 16:00
3.64
+0.01
(+0.28%)
After-Hours: 20:00
Cardiff Oncology Cash from Operations (Quarterly): -7.74M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.74M |
| December 31, 2023 | -7.139M |
| September 30, 2023 | -7.957M |
| June 30, 2023 | -7.132M |
| March 31, 2023 | -8.659M |
| December 31, 2022 | -9.39M |
| September 30, 2022 | -7.486M |
| June 30, 2022 | -6.695M |
| March 31, 2022 | -10.25M |
| December 31, 2021 | -7.39M |
| September 30, 2021 | -5.465M |
| June 30, 2021 | -4.301M |
| March 31, 2021 | -5.884M |
| December 31, 2020 | -5.124M |
| September 30, 2020 | -3.526M |
| June 30, 2020 | -4.291M |
| March 31, 2020 | -3.374M |
| December 31, 2019 | -3.277M |
| September 30, 2019 | -3.188M |
| June 30, 2019 | -3.443M |
| March 31, 2019 | -3.36M |
| December 31, 2018 | -3.613M |
| September 30, 2018 | -3.480M |
| June 30, 2018 | -3.251M |
| March 31, 2018 | -2.856M |
| Date | Value |
|---|---|
| December 31, 2017 | -3.331M |
| September 30, 2017 | -6.594M |
| June 30, 2017 | -4.597M |
| March 31, 2017 | -8.758M |
| December 31, 2016 | -9.005M |
| September 30, 2016 | -7.042M |
| June 30, 2016 | -8.078M |
| March 31, 2016 | -6.916M |
| December 31, 2015 | -6.809M |
| September 30, 2015 | -5.133M |
| June 30, 2015 | -5.444M |
| March 31, 2015 | -4.733M |
| December 31, 2014 | -3.867M |
| September 30, 2014 | -3.408M |
| June 30, 2014 | -2.654M |
| March 31, 2014 | -2.799M |
| December 31, 2013 | -1.855M |
| September 30, 2013 | -2.098M |
| June 30, 2013 | -1.736M |
| March 31, 2013 | -1.629M |
| December 31, 2012 | -1.316M |
| September 30, 2012 | -1.418M |
| June 30, 2012 | -1.296M |
| March 31, 2012 | -0.9051M |
| December 31, 2011 | -0.5206M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.25M
Minimum
Mar 2022
-3.188M
Maximum
Sep 2019
-6.086M
Average
-6.290M
Median
Cash from Operations (Quarterly) Benchmarks
| BioVie Inc | -5.910M |
| Perspective Therapeutics Inc | 13.85M |
| Biolase Inc | -5.938M |
| Tenon Medical Inc | -2.278M |
| Adial Pharmaceuticals Inc | -1.223M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 4.636M |
| Cash from Financing (Quarterly) | 0.107M |
| Free Cash Flow | -30.62M |
| Free Cash Flow Per Share (Quarterly) | -0.175 |
| Free Cash Flow to Equity (Quarterly) | -7.82M |
| Free Cash Flow Yield | -18.88% |